Literature DB >> 7795459

Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients.

J La Puma1, C B Stocking, W D Rhoades, C M Darling, R E Ferner, J Neuberger, M VandenBurg, I Dews, J S Tobias.   

Abstract

Postmarketing research, often called phase IV trials, is intended to familiarise doctors and patients with newly approved drugs. La Puma and colleagues, in Chicago, studied doctors' and patients' attitudes to whether doctors should receive payment for taking part in such research. We asked for commentaries on their findings from four ethical experts, who put the study in a British context, present the views of patients, and examine some methodological assumptions.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1995        PMID: 7795459      PMCID: PMC2550020          DOI: 10.1136/bmj.310.6995.1660

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  Physician rewards for postmarketing surveillance (seeding studies) in the US.

Authors:  J La Puma
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

2.  "How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research.

Authors:  J La Puma; J Kraut
Journal:  Hosp Health Serv Adm       Date:  1994

Review 3.  Marketing aspects of company-sponsored postmarketing surveillance studies.

Authors:  M D Stephens
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

4.  Evaluating drugs after their approval for clinical use.

Authors:  W A Ray; M R Griffin; J Avorn
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

  4 in total
  11 in total

1.  [Psychiatrists and the pharmaceutical industry].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

Review 2.  What do we really know about conflicts of interest in biomedical research?

Authors:  Teddy D Warner; John P Gluck
Journal:  Psychopharmacology (Berl)       Date:  2003-11-18       Impact factor: 4.530

Review 3.  Ethics of undisclosed payments to doctors recruiting patients in clinical trials.

Authors:  Jammi N Rao; L J Sant Cassia
Journal:  BMJ       Date:  2002-07-06

Review 4.  Attitudes of academic and clinical researchers toward financial ties in research: a systematic review.

Authors:  Bonnie E Glaser; Lisa A Bero
Journal:  Sci Eng Ethics       Date:  2005-10       Impact factor: 3.525

5.  The limits of disclosure: what research subjects want to know about investigator financial interests.

Authors:  Christine Grady; Elizabeth Horstmann; Jeffrey S Sussman; Sara Chandros Hull
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

6.  Informed consent to postmarketing research. Patients may feel pressured to participate.

Authors:  N H Cox
Journal:  BMJ       Date:  1995-09-09

7.  Informed consent to postmarketing research. British rules outlaw disguised promotion of drugs.

Authors:  F Wells
Journal:  BMJ       Date:  1995-09-09

8.  Key personnel and "long distance" settings: determining who must report financial conflict of interest.

Authors:  John Lynch; Christopher J Lindsell
Journal:  Account Res       Date:  2010-07       Impact factor: 2.622

9.  Public perceptions of physician - pharmaceutical industry interactions: a systematic review.

Authors:  Janine Arkinson; Anne Holbrook; Wojciech Wiercioch
Journal:  Healthc Policy       Date:  2010-05

10.  Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Authors:  S Y H Kim; R W Millard; P Nisbet; C Cox; E D Caine
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.